Want to track AQST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aquestive Therapeutics Inc. (AQST) Statistics
Valuation metrics
Market Cap 641.14M
Enterprise value 590.35M
Trailing P/E (ttm) -7.72
Forward P/E -
PEG ratio -6.88
Price/Sales (ttm) 11.65
Price/Book (mrq) -11.09
Enterprise Value/Revenue 10.91
Enterprise Value/EBITDA -9.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.51M
Average volume (90 days) 1.95M
Price summary
52-Week low 2.93
52-Week high 7.55
Beta -
50-Day moving average 3.94
200-Day moving average 4.12
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.45%
Operating margin -0.98%
Operational effectiveness
Return on assets -0.59%
Return on equity 2.44%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.43
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.63
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.79
Total debt (mrq) -
Total Debt/Equity (mrq) -1.04
Current ratio (mrq) 7.19%
Book value per share (mrq) -0.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
